The Centre for Central Nervous System Therapeutics (CCNST) exists to support commercial companies and world-leading academics to collaborate more effectively. We facilitate the development of new medication and other therapies for CNS disorders, by creating and maintaining collaborative relationships with relevant commercial and charitable organisations, matching the interests of private sector organisations to research expertise and vice-versa.
The CCNST is a partnership between King’s College London’s Institute of Psychiatry, Psychology & Neuroscience and South London and Maudsley and King’s College Hospital NHS Foundation Trusts.
As part of King’s Health Partners, we have world-class research facilities and expertise available to enhance commercial trials and collaborative research project experience. We act as a signpost and first point of contact for industry, and also promote the benefits of collaborating with industry to researchers, patients and carers across our partnership.
Based at King’s College London’s Denmark Hill campus, the CCNST is led by Sukhwinder Shergill, Professor of Psychiatry and Systems Neuroscience at King’s College London and a consultant psychiatrist at South London and Maudsley NHS Foundation Trust.
Contact Professor Sukhwinder Shergill email@example.com